Jeffrey A. Tice

9.7k total citations · 1 hit paper
123 papers, 6.3k citations indexed

About

Jeffrey A. Tice is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jeffrey A. Tice has authored 123 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 33 papers in Genetics and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Jeffrey A. Tice's work include Global Cancer Incidence and Screening (41 papers), Cancer Risks and Factors (32 papers) and Breast Cancer Treatment Studies (18 papers). Jeffrey A. Tice is often cited by papers focused on Global Cancer Incidence and Screening (41 papers), Cancer Risks and Factors (32 papers) and Breast Cancer Treatment Studies (18 papers). Jeffrey A. Tice collaborates with scholars based in United States, Vietnam and Sweden. Jeffrey A. Tice's co-authors include Karla Kerlikowske, Steven R. Cummings, Michael Pignone, Mark J. Pletcher, Elad Ziv, Warren S. Browner, Diana L. Miglioretti, Rebecca Smith‐Bindman, Daniel A. Ollendorf and William E. Barlow and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jeffrey A. Tice

117 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

2016 267 citations Jeffrey A. Tice et al. profile →

Peers

Countries citing papers authored by Jeffrey A. Tice

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Tice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Tice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Tice more than expected).

Fields of papers citing papers by Jeffrey A. Tice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Tice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Tice. The network helps show where Jeffrey A. Tice may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Tice

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Tice. A scholar is included among the top collaborators of Jeffrey A. Tice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Tice. Jeffrey A. Tice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians 2025 ·Annals of Internal Medicine ·Amir Qaseem, Jeffrey A. Tice, Itziar Etxeandia‐Ikobaltzeta, Timothy J Wilt, Curtis S. Harrod, Thomas G. Cooney, (unknown), (unknown), Lauri A. Hicks, Ethan M. Balk, J. Thomas Cross, Nick Fitterman, Johanna Lewis, Amy M. Linsky, (unknown), (unknown), Matthew C. Miller, Adam J. Obley, Douglas K Owens, Paul G Shekelle, Tatyana Shamliyan, Jennifer Yost	0
2	Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians 2025 ·Annals of Internal Medicine ·Amir Qaseem, Thomas G. Cooney, Itziar Etxeandia‐Ikobaltzeta, Timothy J Wilt, Curtis S. Harrod, Jeffrey A. Tice, Carolyn Crandall, Lauri A. Hicks, J. Thomas Cross, Nick Fitterman, Johanna Lewis, Amy M. Linsky, (unknown), Matthew C. Miller, Adam J. Obley, Douglas K Owens, Paul G Shekelle, Tatyana Shamliyan, Jennifer Yost	3
3	KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council 2024 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), Jeffrey A. Tice, Melanie D. Whittington, Abigail C. Wright, (unknown), (unknown), Steven D. Pearson, David M. Rind, Foluso Agboola	7
4	The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B 2024 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), Jeffrey A. Tice, David M. Rind, Steven D. Pearson, Surrey M. Walton	1
5	Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Karla Kerlikowske, Michael C. S. Bissell, Brian L. Sprague, Jeffrey A. Tice, Katherine Y. Tossas, Erin J. Aiello Bowles, (unknown), Theresa H.M. Keegan, Diana L. Miglioretti	14
6	Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency 2023 ·JAMA Network Open ·Brian L. Sprague, Shuai Chen, Diana L. Miglioretti, Charlotte C. Gard, Jeffrey A. Tice, Rebecca A. Hubbard, Erin J. Aiello Bowles, Peter A. Kaufman, Karla Kerlikowske	1
7	Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium 2021 ·Radiology ·Jeffrey A. Tice, Charlotte C. Gard, Diana L. Miglioretti, Brian L. Sprague, Anna N.A. Tosteson, Bonnie N. Joe, (unknown), Karla Kerlikowske	14
8	Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Kara A. Michels, (unknown), Doug C. Bauer, Louise A. Brinton, Diana S.M. Buist, Jane A. Cauley, Cher M. Dallal, Roni T. Falk, Trisha F. Hue, James V. Lacey, Andrea Z. LaCroix, Jeffrey A. Tice, Xia Xu, Britton Trabert	5
9	Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial 2021 ·npj Breast Cancer ·(unknown), (unknown), Yiwey Shieh, Jeffrey A. Tice, Jeffrey Belkora, Karen Sepucha, (unknown), (unknown), (unknown), Deborah Goodman, Elissa M. Ozanne, Allison Stover Fiscalini, Laura J. Esserman	13
10	Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B∼FIT Cohort 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Britton Trabert, (unknown), Doug C. Bauer, Diana S.M. Buist, Jane A. Cauley, Roni T. Falk, Gretchen L. Gierach, Trisha F. Hue, James V. Lacey, Andrea Z. LaCroix, Kara A. Michels, Jeffrey A. Tice, Xia Xu, Louise A. Brinton, Cher M. Dallal	4
11	Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Michael C. S. Bissell, Karla Kerlikowske, Brian L. Sprague, Jeffrey A. Tice, Charlotte C. Gard, Katherine Y. Tossas, Garth H. Rauscher, Amy Trentham‐Dietz, Louise M. Henderson, Tracy Onega, Theresa H.M. Keegan, Diana L. Miglioretti	43
12	Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis 2018 ·CNS Drugs ·Marita Zimmermann, Elizabeth Brouwer, Jeffrey A. Tice, (unknown), (unknown), Shanshan Liu, Richard H. Chapman, Varun Kumar, Josh J. Carlson	35
13	An Intervention Tool to Increase Patient–Physician Discussion of Lifestyle Risk Factors for Breast Cancer 2018 ·Journal of Women s Health ·Elissa M. Ozanne, Leah Karliner, Jeffrey A. Tice, Jennifer S. Haas, Jennifer Livaudais‐Toman, Rena J. Pasick, Celia P. Kaplan	4
14	Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention 2017 ·PLoS ONE ·Elad Ziv, Jeffrey A. Tice, Brian L. Sprague, Celine M. Vachon, Steven R. Cummings, Karla Kerlikowske	10
15	Breast cancer risk prediction using a clinical risk model and polygenic risk score 2016 ·Breast Cancer Research and Treatment ·Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C. Gard, Jessica W. T. Leung, Jeffrey A. Tice, Celine M. Vachon, Steven R. Cummings, Karla Kerlikowske, Elad Ziv	105
16	The Effect of Change in Body Mass Index on Volumetric Measures of Mammographic Density 2015 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Katherine W. Reeves, Susan R. Sturgeon, Nicholas G Reich, Lynnette Leidy Sievert, Karla Kerlikowske, Lin Ma, John Shepherd, Jeffrey A. Tice, Amir Pasha Mahmoudzadeh, Serghei Malkov, Brian L. Sprague	27
17	One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Karla Kerlikowske, Charlotte C. Gard, Brian L. Sprague, Jeffrey A. Tice, Diana L. Miglioretti	36
18	Changes in Breast Cancer Risk Distribution Among Vermont Women Using Screening Mammography 2014 ·JNCI Journal of the National Cancer Institute ·(unknown), John L. Mace, Pamela M. Vacek, Sally D. Herschorn, Ted A. James, Jeffrey A. Tice, Karla Kerlikowske, (unknown), Donald L. Weaver, Brian L. Sprague	5
19	Ineffectiveness of Sertraline for Treatment of Menopausal Hot Flushes 2007 ·Obstetrics and Gynecology ·Deborah Grady, Beth E. Cohen, Jeffrey A. Tice, Margaret Kristof, (unknown), George F. Sawaya	65
20	What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk 2004 ·SHILAP Revista de lepidopterología ·Mark J. Pletcher, Jeffrey A. Tice, Michael Pignone, Charles E. McCulloch, Tracy Q. Callister, Warren S. Browner	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact